β-Arrestin2 is increased in liver fibrosis in humans and rodents

Schierwagen R, Dietrich P, Klein S, Uschner FE, Ortiz C, Tyc O, Torres S, Hellerbrand C, Sauerbruch T, Trebicka J (2020)

Publication Type: Journal article

Publication year: 2020

Journal

Proceedings of the National Academy of Sciences of the United States of America National Academy of Sciences

Book Volume: 117

Pages Range: 27082-27084

Journal Issue: 44

DOI: 10.1073/pnas.2014337117

Authors with CRIS profile

Peter Dietrich Lehrstuhl für Biochemie und Molekulare Medizin Claus Hellerbrand Professur für Biochemie und Molekulare Pathobiologie

Additional Organisation(s)

Interdisziplinäres Zentrum für Klinische Forschung (IZKF)

Related research project(s)

D032: The role of neuropeptide Y in chemo-resistance and immune checkpoint inhibition in hepatocellular carcinoma March 1, 2020 - Feb. 28, 2023

Involved external institutions

Goethe-Universität Frankfurt am Main DE Germany (DE) Rheinische Friedrich-Wilhelms-Universität Bonn DE Germany (DE)

How to cite

APA:

Schierwagen, R., Dietrich, P., Klein, S., Uschner, F.E., Ortiz, C., Tyc, O.,... Trebicka, J. (2020). β-Arrestin2 is increased in liver fibrosis in humans and rodents. Proceedings of the National Academy of Sciences of the United States of America, 117(44), 27082-27084. https://doi.org/10.1073/pnas.2014337117

MLA:

Schierwagen, Robert, et al. "β-Arrestin2 is increased in liver fibrosis in humans and rodents." Proceedings of the National Academy of Sciences of the United States of America 117.44 (2020): 27082-27084.

BibTeX: Download